Clinical data specifically addressing the effects of incretin-based therapeutics on DN remain limited, despite compelling preclinical evidence of their favorable metabolic effects, which support their further evaluation
Dosing, continuation, or discontinuation decisions are controlled by clinicians and are not set or enforced by the platform
Rare but serious complications include pancreatitis, gallbladder issues, and retinopathy changes in patients with existing diabetic retinopathy
The key to sustainable weight loss is building habits that support not just the medication, but your overall health
Its primarily used to treat type 2 diabetes a chronic metabolic condition that occurs when the body cant use insulin properly its weight loss benefits are really what nailed down its popularity
To be a successful applicant, you need to either have a BMI of 27 kg/m2 or higher while also having a weight-related condition or have a BMI of 30 kg/m2 or higher